{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:15:15Z","timestamp":1793834115295,"version":"4.6.1"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T00:00:00Z","timestamp":1595980800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"crossref","award":["CAIN457AAR02T"],"award-info":[{"award-number":["CAIN457AAR02T"]}],"id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is an immune-mediated skin disorder. Imbalance of gut microbial populations has been implicated in many diseases. We aimed to investigate whether there were differences in gut microbiota in psoriasis patients vs non-psoriasis controls and between psoriasis severity groups. 55 psoriasis patients and 27 controls were included. V3\u2013V4 regions of the 16S rRNA gene of fecal samples were analyzed using Illumina MiSeq. Bioinformatic analysis was performed. We found changes in gut microbiome composition depending on their psoriasis status as determined by weighted unifrac (p\u2009&lt;\u20090.05), in particular an increase in Firmicutes and depletion of Bacteroidetes in psoriasis patients. Additionally, the\n                    <jats:italic>Faecalibacterium<\/jats:italic>\n                    and\n                    <jats:italic>Blautia<\/jats:italic>\n                    genus were higher in psoriasis patients while\n                    <jats:italic>Bacteroides<\/jats:italic>\n                    and\n                    <jats:italic>Paraprevotella<\/jats:italic>\n                    in non-psoriasis controls (p\u2009&lt;\u20090.05, LDA score\u2009&gt;\u20092). Moderate-to-severe psoriasis patients had lower biodiversity than mild psoriatic patients (p\u2009=\u20090.049). No differences for beta-diversity were found. We developed a Psoriasis-Microbiota Index (PMI), which discriminated among psoriasis patients and controls with sensitivity: 0.78 and specificity: 0.79. Furthermore, we performed a meta-analysis with published data to validate this index. We demonstrated gut dysbiosis in psoriasis patients, suggesting a role in psoriasis pathophysiology. Furthermore, we developed a PMI with the potential to discriminate between psoriasis patients and controls across different populations, which could be used as a biomarker in the clinical practice.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-69537-3","type":"journal-article","created":{"date-parts":[[2020,7,29]],"date-time":"2020-07-29T06:04:12Z","timestamp":1596002652000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["Metagenomic analysis of gut microbiota in non-treated plaque psoriasis patients stratified by disease severity: development of a new Psoriasis-Microbiome Index"],"prefix":"10.1038","volume":"10","author":[{"given":"Ignacio","family":"Dei-Cas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florencia","family":"Giliberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonela","family":"Luce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n","family":"Dopazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Penas-Steinhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,7,29]]},"reference":[{"key":"69537_CR1","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","volume":"370","author":"CEM Griffiths","year":"2007","unstructured":"Griffiths, C. E. M. & Barker, J. N. Pathogenesis and clinical features of psoriasis. The Lancet 370, 263\u2013271 (2007).","journal-title":"The Lancet"},{"key":"69537_CR2","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","volume":"60","author":"SK Kurd","year":"2009","unstructured":"Kurd, S. K. & Gelfand, J. M. The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003\u20132004. J. Am. Acad. Dermatol. 60, 218\u2013224 (2009).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69537_CR3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0190-9622(99)70112-X","volume":"41","author":"SR Rapp","year":"1999","unstructured":"Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B. Jr. & Reboussin, D. M. Psoriasis causes as much disability as other major medical diseases. J. Am. Acad. Dermatol. 41, 401\u2013407 (1999).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69537_CR4","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2014.12.014","volume":"73","author":"J Baliwag","year":"2015","unstructured":"Baliwag, J., Barnes, D. H. & Johnston, A. Cytokines in psoriasis. Cytokine 73, 342\u2013350 (2015).","journal-title":"Cytokine"},{"key":"69537_CR5","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.gene.2018.09.042","volume":"683","author":"S Singh","year":"2019","unstructured":"Singh, S. et al. Genomic alterations driving psoriasis pathogenesis. Gene 683, 61\u201371 (2019).","journal-title":"Gene"},{"key":"69537_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s11427-018-9376-6","author":"L Huang","year":"2018","unstructured":"Huang, L. et al. Dysbiosis of gut microbiota was closely associated with psoriasis. Sci. China Life Sci. https:\/\/doi.org\/10.1007\/s11427-018-9376-6 (2018).","journal-title":"Sci. China Life Sci."},{"key":"69537_CR7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/nature11234","volume":"486","author":"The Human Microbiome Project Consortium","year":"2012","unstructured":"The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486, 207\u2013214 (2012).","journal-title":"Nature"},{"key":"69537_CR8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.revmed.2015.12.012","volume":"37","author":"C Landman","year":"2016","unstructured":"Landman, C. & Qu\u00e9vrain, E. Gut microbiota: description, role and pathophysiologic implications. Rev. Med. Int. 37, 418\u2013423 (2016).","journal-title":"Rev. Med. Int."},{"key":"69537_CR9","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.3390\/ijms19123827","volume":"19","author":"L Carrera-Quintanar","year":"2018","unstructured":"Carrera-Quintanar, L. et al. The human microbiota and obesity: a literature systematic review of in vivo models and technical approaches. Int. J. Mol. Sci. 19, 3827 (2018).","journal-title":"Int. J. Mol. Sci."},{"key":"69537_CR10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11892-018-1104-3","volume":"18","author":"X Chen","year":"2018","unstructured":"Chen, X. & Devaraj, S. Gut Microbiome in Obesity, Metabolic Syndrome, and Diabetes. Curr. Diab. Rep. 18, 129 (2018).","journal-title":"Curr. Diab. Rep."},{"key":"69537_CR11","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.12740\/PP\/OnlineFirst\/81103","volume":"52","author":"E Gulas","year":"2018","unstructured":"Gulas, E., Wysiadecki, G., Strzelecki, D., Gawlik-Kotelnicka, O. & Polguj, M. Can microbiology affect psychiatry? A link between gut microbiota and psychiatric disorders. Psychiatr. Pol. 52, 1023\u20131039 (2018).","journal-title":"Psychiatr. Pol."},{"key":"69537_CR12","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3899\/jrheum.180135","volume":"94","author":"E Gilis","year":"2018","unstructured":"Gilis, E. et al. The role of the microbiome in gut and joint inflammation in psoriatic arthritis and spondyloarthritis. J. Rheumatol. Suppl. 94, 36\u201339 (2018).","journal-title":"J. Rheumatol. Suppl."},{"issue":"Suppl 2","key":"69537_CR13","doi-asserted-by":"crossref","first-page":"S148","DOI":"10.1097\/MCG.0000000000000688","volume":"50","author":"MC Cenit","year":"2016","unstructured":"Cenit, M. C., Codo\u00f1er-Franch, P. & Sanz, Y. Gut microbiota and risk of developing celiac disease. J. Clin. Gastroenterol. 50(Suppl 2), S148\u2013S152 (2016).","journal-title":"J. Clin. Gastroenterol."},{"key":"69537_CR14","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jaad.2016.07.064","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita, J. et al. Psoriasis and comorbid diseases: Epidemiology. J. Am. Acad. Dermatol. 76, 377\u2013390 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69537_CR15","first-page":"1241","volume":"27","author":"R Scarpa","year":"2000","unstructured":"Scarpa, R. et al. Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J. Rheumatol. 27, 1241\u20131246 (2000).","journal-title":"J. Rheumatol."},{"key":"69537_CR16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1001\/jamadermatol.2014.5585","volume":"151","author":"A Ram\u00edrez-Bosc\u00e1","year":"2015","unstructured":"Ram\u00edrez-Bosc\u00e1, A. et al. Identification of bacterial DNA in the peripheral blood of patients with active psoriasis. JAMA Dermatol. 151, 670\u2013671 (2015).","journal-title":"JAMA Dermatol."},{"key":"69537_CR17","doi-asserted-by":"crossref","first-page":"3812","DOI":"10.1038\/s41598-018-22125-y","volume":"8","author":"FM Codo\u00f1er","year":"2018","unstructured":"Codo\u00f1er, F. M. et al. Gut microbial composition in patients with psoriasis. Sci. Rep. 8, 3812 (2018).","journal-title":"Sci. Rep."},{"key":"69537_CR18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcimb.2019.00007","volume":"9","author":"MJE Visser","year":"2019","unstructured":"Visser, M. J. E., Kell, D. B. & Pretorius, E. Bacterial dysbiosis and translocation in psoriasis vulgaris. Front. Cell. Infect. Microbiol. 9, 7 (2019).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"69537_CR19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A. & Chiricozzi, A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 55, 379\u2013390 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"69537_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.cell.2015.08.058","volume":"163","author":"K Atarashi","year":"2015","unstructured":"Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367\u2013380 (2015).","journal-title":"Cell"},{"key":"69537_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/nature24628","author":"N Wilck","year":"2017","unstructured":"Wilck, N. et al. Salt-responsive gut commensal modulates TH17 axis and disease. Nature https:\/\/doi.org\/10.1038\/nature24628 (2017).","journal-title":"Nature"},{"key":"69537_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12950","author":"KL Flannigan","year":"2018","unstructured":"Flannigan, K. L. & Denning, T. L. Segmented filamentous bacteria-induced immune responses: a balancing act between host protection and autoimmunity. Immunology https:\/\/doi.org\/10.1111\/imm.12950 (2018).","journal-title":"Immunology"},{"key":"69537_CR23","doi-asserted-by":"crossref","first-page":"e0159539","DOI":"10.1371\/journal.pone.0159539","volume":"11","author":"Z Z\u00e1kostelsk\u00e1","year":"2016","unstructured":"Z\u00e1kostelsk\u00e1, Z. et al. Intestinal microbiota promotes psoriasis-like skin inflammation by enhancing Th17 response. PLoS ONE 11, e0159539 (2016).","journal-title":"PLoS ONE"},{"key":"69537_CR24","doi-asserted-by":"crossref","first-page":"8424","DOI":"10.1038\/ncomms9424","volume":"6","author":"P Zanvit","year":"2015","unstructured":"Zanvit, P. et al. Antibiotics in neonatal life increase murine susceptibility to experimental psoriasis. Nat. Commun. 6, 8424 (2015).","journal-title":"Nat. Commun."},{"key":"69537_CR25","doi-asserted-by":"crossref","first-page":"236","DOI":"10.3389\/fmicb.2019.00236","volume":"10","author":"Z Stehlikova","year":"2019","unstructured":"Stehlikova, Z. et al. Crucial role of microbiota in experimental psoriasis revealed by a gnotobiotic mouse model. Front. Microbiol. 10, 236 (2019).","journal-title":"Front. Microbiol."},{"key":"69537_CR26","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/exd.13463","volume":"27","author":"L Tan","year":"2018","unstructured":"Tan, L. et al. The Akkermansia muciniphila is a gut microbiota signature in psoriasis. Exp. Dermatol. 27, 144\u2013149 (2018).","journal-title":"Exp. Dermatol."},{"key":"69537_CR27","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1111\/exd.13786","volume":"27","author":"Y-J Chen","year":"2018","unstructured":"Chen, Y.-J. et al. Intestinal microbiota profiling and predicted metabolic dysregulation in psoriasis patients. Exp. Dermatol. 27, 1336\u20131343 (2018).","journal-title":"Exp. Dermatol."},{"key":"69537_CR28","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s40168-018-0533-1","volume":"6","author":"H-W Chang","year":"2018","unstructured":"Chang, H.-W. et al. Alteration of the cutaneous microbiome in psoriasis and potential role in Th17 polarization. Microbiome 6, 154 (2018).","journal-title":"Microbiome"},{"key":"69537_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/art.38892","volume":"67","author":"JU Scher","year":"2015","unstructured":"Scher, J. U. et al. Decreased bacterial diversity characterizes the altered gut microbiota in patients with psoriatic arthritis, resembling dysbiosis in inflammatory bowel disease. Arthritis Rheumatol 67, 128\u2013139 (2015).","journal-title":"Arthritis Rheumatol"},{"key":"69537_CR30","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/ecco-jcc\/jjw070","volume":"10","author":"H Eppinga","year":"2016","unstructured":"Eppinga, H. et al. Similar depletion of protective Faecalibacterium prausnitziiin psoriasis and inflammatory bowel disease, but not in hidradenitis suppurativa. J. Crohn\u2019s Colitis 10, 1067\u20131075 (2016).","journal-title":"J. Crohn\u2019s Colitis"},{"key":"69537_CR31","doi-asserted-by":"crossref","first-page":"e360","DOI":"10.1111\/bjd.16617","volume":"178","author":"EA Langan","year":"2018","unstructured":"Langan, E. A. et al. The role of the microbiome in psoriasis: moving from disease description to treatment prediction?. Br. J. Dermatol. 178, e360\u2013e360 (2018).","journal-title":"Br. J. Dermatol."},{"key":"69537_CR32","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41522-017-0022-5","volume":"3","author":"A Tett","year":"2017","unstructured":"Tett, A. et al. Unexplored diversity and strain-level structure of the skin microbiome associated with psoriasis. NPJ Biofilms Microbiomes 3, 14 (2017).","journal-title":"NPJ Biofilms Microbiomes"},{"key":"69537_CR33","doi-asserted-by":"crossref","first-page":"S112","DOI":"10.1016\/j.jid.2017.02.670","volume":"137","author":"S Nakajima","year":"2017","unstructured":"Nakajima, S., Harrison, O., Merrill, E., Linehan, J. & Belkaid, Y. 648 Candida albicans colonization exacerbates skin inflammation in a murine model of psoriasis. J. Invest. Dermatol. 137, S112 (2017).","journal-title":"J. Invest. Dermatol."},{"key":"69537_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17931","author":"C Hidalgo-Cantabrana","year":"2019","unstructured":"Hidalgo-Cantabrana, C. et al. Gut microbiota dysbiosis in a cohort of patients with psoriasis. Br. J. Dermatol. https:\/\/doi.org\/10.1111\/bjd.17931 (2019).","journal-title":"Br. J. Dermatol."},{"key":"69537_CR35","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/1346-8138.14933","volume":"46","author":"J Shapiro","year":"2019","unstructured":"Shapiro, J. et al. Psoriatic patients have a distinct structural and functional fecal microbiota compared with controls. J. Dermatol. 46, 595\u2013603 (2019).","journal-title":"J. Dermatol."},{"key":"69537_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.06.024","author":"C Quan","year":"2019","unstructured":"Quan, C. et al. Psoriatic lesions are characterized by higher bacterial load and imbalance between Cutibacterium and Corynebacterium. J. Am. Acad. Dermatol. https:\/\/doi.org\/10.1016\/j.jaad.2019.06.024 (2019).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69537_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.17989","author":"EA Langan","year":"2019","unstructured":"Langan, E. A. et al. Combined culture and metagenomic analyses reveal significant shifts in the composition of the cutaneous microbiome in psoriasis. Br. J. Dermatol. https:\/\/doi.org\/10.1111\/bjd.17989 (2019).","journal-title":"Br. J. Dermatol."},{"key":"69537_CR38","doi-asserted-by":"crossref","first-page":"438","DOI":"10.3389\/fmicb.2019.00438","volume":"10","author":"Z Stehlikova","year":"2019","unstructured":"Stehlikova, Z. et al. Dysbiosis of skin microbiota in psoriatic patients: co-occurrence of fungal and bacterial communities. Front. Microbiol. 10, 438 (2019).","journal-title":"Front. Microbiol."},{"key":"69537_CR39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.3934\/microbiol.2018.4.642","volume":"4","author":"E Sayers","year":"2018","unstructured":"Sayers, E., MacGregor, A. & Carding, S. R. Drug-microbiota interactions and treatment response: relevance to rheumatoid arthritis. AIMS Microbiol 4, 642\u2013654 (2018).","journal-title":"AIMS Microbiol"},{"key":"69537_CR40","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2019.07.025","author":"K Aden","year":"2019","unstructured":"Aden, K. et al. Metabolic functions of gut microbes associate with efficacy of tumor necrosis factor antagonists in patients with inflammatory bowel diseases. Gastroenterology https:\/\/doi.org\/10.1053\/j.gastro.2019.07.025 (2019).","journal-title":"Gastroenterology"},{"key":"69537_CR41","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02120-17","author":"MK Doherty","year":"2018","unstructured":"Doherty, M. K. et al. Fecal microbiota signatures are associated with response to Ustekinumab therapy among Crohn\u2019s disease patients. mBio https:\/\/doi.org\/10.1128\/mBio.02120-17 (2018).","journal-title":"mBio"},{"key":"69537_CR42","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.cell.2014.09.053","volume":"159","author":"JK Goodrich","year":"2014","unstructured":"Goodrich, J. K. et al. Human genetics shape the gut microbiome. Cell 159, 789\u2013799 (2014).","journal-title":"Cell"},{"key":"69537_CR43","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/nature07540","volume":"457","author":"PJ Turnbaugh","year":"2009","unstructured":"Turnbaugh, P. J. et al. A core gut microbiome in obese and lean twins. Nature 457, 480\u2013484 (2009).","journal-title":"Nature"},{"key":"69537_CR44","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.jaad.2016.07.065","volume":"76","author":"J Takeshita","year":"2017","unstructured":"Takeshita, J. et al. Psoriasis and comorbid diseases: implications for management. J. Am. Acad. Dermatol. 76, 393\u2013403 (2017).","journal-title":"J. Am. Acad. Dermatol."},{"key":"69537_CR45","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrgastro.2017.88","volume":"14","author":"J Ni","year":"2017","unstructured":"Ni, J., Wu, G. D., Albenberg, L. & Tomov, V. T. Gut microbiota and IBD: causation or correlation?. Nature Reviews Gastroenterology & Hepatology 14, 573\u2013584 (2017).","journal-title":"Nature Reviews Gastroenterology & Hepatology"},{"key":"69537_CR46","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.chom.2017.10.005","volume":"22","author":"P Maruvada","year":"2017","unstructured":"Maruvada, P., Leone, V., Kaplan, L. M. & Chang, E. B. The human microbiome and obesity: moving beyond associations. Cell Host Microbe 22, 589\u2013599 (2017).","journal-title":"Cell Host Microbe"},{"key":"69537_CR47","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/postgradmedj-2015-133285","volume":"92","author":"E Patterson","year":"2016","unstructured":"Patterson, E. et al. Gut microbiota, obesity and diabetes. Postgrad. Med. J. 92, 286\u2013300 (2016).","journal-title":"Postgrad. Med. J."},{"key":"69537_CR48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/ana.24901","volume":"81","author":"H Tremlett","year":"2017","unstructured":"Tremlett, H., Bauer, K. C., Appel-Cresswell, S., Finlay, B. B. & Waubant, E. The gut microbiome in human neurological disease: a review. Ann. Neurol. 81, 369\u2013382 (2017).","journal-title":"Ann. Neurol."},{"key":"69537_CR49","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.jaci.2015.08.021","volume":"137","author":"H Song","year":"2016","unstructured":"Song, H., Yoo, Y., Hwang, J., Na, Y.-C. & Kim, H. S. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis. J. Allergy Clin. Immunol. 137, 852\u2013860 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"69537_CR50","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-4155-7_1","author":"A Saha","year":"2019","unstructured":"Saha, A. & Robertson, E. S. Microbiome and human malignancies. Microbiome Cancer https:\/\/doi.org\/10.1007\/978-3-030-4155-7_1 (2019).","journal-title":"Microbiome Cancer"},{"key":"69537_CR51","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nature12506","volume":"500","author":"EL Chatelier","year":"2013","unstructured":"Chatelier, E. L. et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541\u2013546 (2013).","journal-title":"Nature"},{"key":"69537_CR52","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/ni0111-5","volume":"12","author":"KM Maslowski","year":"2011","unstructured":"Maslowski, K. M. & Mackay, C. R. Diet, gut microbiota and immune responses. Nat. Immunol. 12, 5\u20139 (2011).","journal-title":"Nat. Immunol."},{"key":"69537_CR53","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/ismej.2016.176","volume":"11","author":"M Lopez-Siles","year":"2017","unstructured":"Lopez-Siles, M., Duncan, S. H., Garcia-Gil, L. J. & Martinez-Medina, M. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11, 841\u2013852 (2017).","journal-title":"ISME J."},{"key":"69537_CR54","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.3390\/nu10101499","volume":"10","author":"KE Bach Knudsen","year":"2018","unstructured":"Bach Knudsen, K. E. et al. Impact of diet-modulated butyrate production on intestinal barrier function and inflammation. Nutrients 10, 1499 (2018).","journal-title":"Nutrients"},{"key":"69537_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izy182","author":"L Zhou","year":"2018","unstructured":"Zhou, L. et al. Faecalibacterium prausnitzii produces butyrate to maintain Th17\/Treg balance and to ameliorate colorectal colitis by inhibiting histone deacetylase 1. Inflamm. Bowel Dis. https:\/\/doi.org\/10.1093\/ibd\/izy182 (2018).","journal-title":"Inflamm. Bowel Dis."},{"key":"69537_CR56","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3389\/fmicb.2018.00346","volume":"9","author":"R Mart\u00edn","year":"2018","unstructured":"Mart\u00edn, R., Berm\u00fadez-Humar\u00e1n, L. G. & Langella, P. Searching for the bacterial effector: the example of the multi-skilled commensal bacterium. Front. Microbiol. 9, 346 (2018).","journal-title":"Front. Microbiol."},{"key":"69537_CR57","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1186\/s12864-018-5313-6","volume":"19","author":"CB Fitzgerald","year":"2018","unstructured":"Fitzgerald, C. B. et al. Comparative analysis of Faecalibacterium prausnitzii genomes shows a high level of genome plasticity and warrants separation into new species-level taxa. BMC Genom. 19, 931 (2018).","journal-title":"BMC Genom."},{"key":"69537_CR58","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1128\/AEM.06858-11","volume":"78","author":"M Lopez-Siles","year":"2012","unstructured":"Lopez-Siles, M. et al. Cultured representatives of two major phylogroups of human colonic Faecalibacterium prausnitzii can utilize pectin, uronic acids, and host-derived substrates for growth. Appl. Environ. Microbiol. 78, 420\u2013428 (2012).","journal-title":"Appl. Environ. Microbiol."},{"key":"69537_CR59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.anaerobe.2016.12.001","volume":"43","author":"GA Durand","year":"2017","unstructured":"Durand, G. A. et al. Blautia massiliensis sp. nov., isolated from a fresh human fecal sample and emended description of the genus Blautia. Anaerobe 43, 47\u201355 (2017).","journal-title":"Anaerobe"},{"key":"69537_CR60","unstructured":"Website. https:\/\/www.ncbi.nlm.nih.gov\/Taxonomy\/Browser\/wwwtax.cgi?mode=Undef&id=572511&lvl=3&keep=1&srchmode=1&unlock [accessed on 24 August 2019]."},{"key":"69537_CR61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3920\/BM2014.0133","volume":"6","author":"M Touyama","year":"2015","unstructured":"Touyama, M., Jin, J. S., Kibe, R., Hayashi, H. & Benno, Y. Quantification of Blautia wexlerae and Blautia luti in human faeces by real-time PCR using specific primers. Benef. Microbes 6, 583\u2013590 (2015).","journal-title":"Benef. Microbes"},{"key":"69537_CR62","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.bbmt.2015.04.016","volume":"21","author":"RR Jenq","year":"2015","unstructured":"Jenq, R. R. et al. Intestinal blautia is associated with reduced death from graft-versus-host disease. Biol. Blood Marrow Transplant. 21, 1373\u20131383 (2015).","journal-title":"Biol. Blood Marrow Transplant."},{"key":"69537_CR63","doi-asserted-by":"crossref","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj, J. S. et al. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am. J. Physiol. Gastrointest. Liver Physiol. 303, G675\u2013G685 (2012).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"69537_CR64","doi-asserted-by":"crossref","first-page":"e39743","DOI":"10.1371\/journal.pone.0039743","volume":"7","author":"W Chen","year":"2012","unstructured":"Chen, W., Liu, F., Ling, Z., Tong, X. & Xiang, C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 7, e39743 (2012).","journal-title":"PLoS ONE"},{"key":"69537_CR65","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1080\/01635581.2017.1263750","volume":"69","author":"TH Luu","year":"2017","unstructured":"Luu, T. H. et al. Intestinal proportion of Blautia sp. is associated with clinical stage and histoprognostic grade in patients with early-stage breast cancer. Nutr. Cancer 69, 267\u2013275 (2017).","journal-title":"Nutr. Cancer"},{"key":"69537_CR66","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-019-0258-z","volume":"17","author":"A Lavelle","year":"2020","unstructured":"Lavelle, A. & Sokol, H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat. Rev. Gastroenterol. Hepatol. 17, 223\u2013237 (2020).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"69537_CR67","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41586-019-1237-9","volume":"569","author":"J Lloyd-Price","year":"2019","unstructured":"Lloyd-Price, J. et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases. Nature 569, 655\u2013662 (2019).","journal-title":"Nature"},{"key":"69537_CR68","unstructured":"Taxonomy. Taxonomy browser (Bacteroides). https:\/\/www.ncbi.nlm.nih.gov\/Taxonomy\/Browser\/wwwtax.cgi?mode=Info&id=816."},{"key":"69537_CR69","unstructured":"Website. Taxonomy browser (Paraprevotella) [WWW Document]. URL https:\/\/www.ncbi.nlm.nih.gov\/Taxonomy\/Browser\/wwwtax.cgi?mode=Info&id=577309&lvl=3&lin=f&keep=1&srchmode=1&unlock [accessed on 24 August 2019]."},{"key":"69537_CR70","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41564-017-0079-1","volume":"3","author":"AS Luis","year":"2018","unstructured":"Luis, A. S. et al. Dietary pectic glycans are degraded by coordinated enzyme pathways in human colonic Bacteroides. Nat Microbiol 3, 210\u2013219 (2018).","journal-title":"Nat Microbiol"},{"key":"69537_CR71","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-019-10012-z","author":"RP Singh","year":"2019","unstructured":"Singh, R. P. Glycan utilisation system in Bacteroides and Bifidobacteria and their roles in gut stability and health. Appl. Microbiol. Biotechnol. https:\/\/doi.org\/10.1007\/s00253-019-10012-z (2019).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"69537_CR72","first-page":"136","volume":"2","author":"J-C Lagier","year":"2012","unstructured":"Lagier, J.-C., Million, M., Hugon, P., Armougom, F. & Raoult, D. Human gut microbiota: repertoire and variations. Front. Cell. Infect. Microbiol. 2, 136 (2012).","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"69537_CR73","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3389\/fmicb.2019.00965","volume":"10","author":"FS Belforte","year":"2019","unstructured":"Belforte, F. S. et al. Getting to know the gut microbial diversity of metropolitan Buenos Aires inhabitants. Front. Microbiol. 10, 965 (2019).","journal-title":"Front. Microbiol."},{"key":"69537_CR74","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0394-z","author":"MGI Langille","year":"2018","unstructured":"Langille, M. G. I., Ravel, J. & Florian Fricke, W. \u2018Available upon request\u2019: not good enough for microbiome data!. Microbiome https:\/\/doi.org\/10.1186\/s40168-017-0394-z (2018).","journal-title":"Microbiome"},{"key":"69537_CR75","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1111\/1574-6941.12008","volume":"83","author":"MA Gray","year":"2013","unstructured":"Gray, M. A., Pratte, Z. A. & Kellogg, C. A. Comparison of DNA preservation methods for environmental bacterial community samples. FEMS Microbiol. Ecol. 83, 468\u2013477 (2013).","journal-title":"FEMS Microbiol. Ecol."},{"key":"69537_CR76","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger, A. M., Lohse, M. & Usadel, B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics 30, 2114\u20132120 (2014).","journal-title":"Bioinformatics"},{"key":"69537_CR77","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nmeth.f.303","volume":"7","author":"JG Caporaso","year":"2010","unstructured":"Caporaso, J. G. et al. QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 7, 335\u2013336 (2010).","journal-title":"Nat. Methods"},{"key":"69537_CR78","doi-asserted-by":"crossref","first-page":"5069","DOI":"10.1128\/AEM.03006-05","volume":"72","author":"TZ DeSantis","year":"2006","unstructured":"DeSantis, T. Z. et al. Greengenes, a chimera-checked 16S rRNA gene database and workbench compatible with ARB. Appl. Environ. Microbiol. 72, 5069\u20135072 (2006).","journal-title":"Appl. Environ. Microbiol."},{"key":"69537_CR79","doi-asserted-by":"crossref","first-page":"e2584","DOI":"10.7717\/peerj.2584","volume":"4","author":"T Rognes","year":"2016","unstructured":"Rognes, T., Flouri, T., Nichols, B., Quince, C. & Mah\u00e9, F. VSEARCH: a versatile open source tool for metagenomics. PeerJ 4, e2584 (2016).","journal-title":"PeerJ"},{"key":"69537_CR80","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/bioinformatics\/bts611","volume":"28","author":"E Kopylova","year":"2012","unstructured":"Kopylova, E., No\u00e9, L. & Touzet, H. SortMeRNA: fast and accurate filtering of ribosomal RNAs in metatranscriptomic data. Bioinformatics 28, 3211\u20133217 (2012).","journal-title":"Bioinformatics"},{"key":"69537_CR81","unstructured":"Mercier, C., Boyer, F., Bonin, A. & Coissac, E. SUMATRA and SUMACLUST: fast and exact comparison and clustering of sequences. GitLab https:\/\/git.metabarcoding.org\/obitools\/sumaclust\/wikis\/home (2013)."},{"key":"69537_CR82","doi-asserted-by":"publisher","DOI":"10.1128\/mSystems.00127-16","author":"AM Comeau","year":"2017","unstructured":"Comeau, A. M., Douglas, G. M. & Langille, M. G. I. Microbiome Helper: a custom and streamlined workflow for microbiome Research. mSystems https:\/\/doi.org\/10.1128\/mSystems.00127-16 (2017).","journal-title":"mSystems"},{"key":"69537_CR83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini, Y. & Hochberg, Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. B 57, 289\u2013300 (1995).","journal-title":"J. R. Stat. Soc. B"},{"key":"69537_CR84","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12859-015-0640-y","volume":"16","author":"CA Lozupone","year":"2015","unstructured":"Lozupone, C. A. & Knight, R. The UniFrac significance test is sensitive to tree topology. BMC Bioinform. 16, 211 (2015).","journal-title":"BMC Bioinform."},{"key":"69537_CR85","doi-asserted-by":"crossref","first-page":"R60","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"69537_CR86","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.chom.2014.02.005","volume":"15","author":"D Gevers","year":"2014","unstructured":"Gevers, D. et al. The treatment-naive microbiome in new-onset Crohn\u2019s disease. Cell Host Microbe 15, 382\u2013392 (2014).","journal-title":"Cell Host Microbe"},{"key":"69537_CR87","doi-asserted-by":"crossref","first-page":"3940","DOI":"10.1093\/bioinformatics\/bti623","volume":"21","author":"T Sing","year":"2005","unstructured":"Sing, T., Sander, O., Beerenwinkel, N. & Lengauer, T. ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940\u20133941 (2005).","journal-title":"Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69537-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69537-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,10]],"date-time":"2024-08-10T19:54:35Z","timestamp":1723319675000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-69537-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,29]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["69537"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-69537-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,29]]},"assertion":[{"value":"24 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr Dei-Cas has received compensation as a speaker, consultant, and investigator for Novartis, Eli Lilly and Janssen. Dr Penas-Steinhardt has received compensation as a speaker for Novartis. Dr Florecina Giliberto, Dr. Leonela Luce and Dr. Hern\u00e1n Dopazo declare no competing interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12754"}}